文献速递心力衰竭与心肌病

经静脉导线拔除术后5年死亡风险LIFE-5S评分开发与验证

Development and Validation of the LIFE‐5S Score for Predicting 5‐Year Mortality After Transvenous Lead Extraction
RSS 订阅 · Journal of Cardiovascular Electrophysiology · 2026-07-08

本研究基于2006至2020年多中心3368例经静脉导线拔除(TLE)患者,按1:1分为推导与验证队列,开发并验证LIFE-5S评分以预测术后5年死亡风险。评分纳入男性、高龄、永久性房颤、晚期心衰、2型糖尿病、肾功能不全、左室射血分数降低、囊袋感染、导线相关感染性心内膜炎及心脏再同步化治疗。评分每升高1分死亡风险增加36%,推导与验证队列AUC分别为0.786和0.785。

要点

  • LIFE-5S评分为0–15分,用于TLE术后5年死亡风险分层。
  • 评分每增加1分,死亡风险升高36%(HR 1.36,95%CI 1.33–1.39)。
  • 可通过在线工具快速计算,辅助术后随访策略制定。

核心结论

  • LIFE-5S评分可为经静脉导线拔除术后患者提供简便的长期预后分层工具。
  • 该模型可辅助临床决策、患者沟通及个体化随访策略制定。

研究设计与样本

  • 回顾性多中心研究纳入2006至2020年间3368例连续TLE患者,均有完整5年随访。
  • 患者按1:1比例分为推导队列(1684例)与验证队列(1684例)。
  • 采用多变量Cox比例风险分析确定死亡的独立预测因素。

主要发现

  • 全队列随访期间5年累计死亡率为32.2%。
  • LIFE-5S评分每升高1分与死亡风险增加相关(HR 1.36,95%CI 1.33–1.39;p<0.001)。
  • 推导队列AUC为0.786,验证队列AUC为0.785,校准良好。

关键数值与推荐

  • 评分独立预测因素包括男性、高龄、永久性房颤、NYHA III/IV级心衰、2型糖尿病、肾功能不全。
  • 评分独立预测因素还包括左室射血分数降低、囊袋感染、导线相关感染性心内膜炎及心脏再同步化治疗。
  • LIFE-5S评分范围0–15分,在线计算工具为https://usuwanieelektrod.pl/life5scalculator。

临床怎么用

  • 可用于TLE术后患者的长期死亡风险床旁评估与分层。
  • 评分结果为个体化随访计划提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

LIFE-5S score for long-term prognostic stratification after transvenous lead extraction. Clinical variables associated with mortality after TLE are incorporated into a simple point-based model (0–15 points). The score allows estimation of 5-year mortality risk and can be calculated using an online tool (https://usuwanieelektrod.pl/life5scalculator). ABSTRACT Introduction Long-term mortality after transvenous lead extraction (TLE) remains substantial despite high procedural success. However, simple tools for estimating long-term prognosis after successful TLE are lacking. Methods and Results This retrospective multicenter study included 3368 consecutive patients undergoing TLE between 2006 and 2020 with complete 5-year follow-up. Patients were assigned in a 1:1 ratio to derivation and validation cohorts (n = 1684 each). Independent predictors of mortality were identified using multivariable Cox proportional hazards analysis and incorporated into a point-based risk score, the List of Independent Factors for Estimated 5-Year Survival (LIFE-5S). During follow-up, cumulative 5-year mortality was 32.2%. Independent predictors included male sex, older age, permanent atrial fibrillation, advanced heart failure (NYHA class III/IV), type 2 diabetes, renal dysfunction, reduced left ventricular ejection fraction, pocket infection, lead-related infective endocarditis, and the presence of cardiac resynchronization therapy. Each 1-point increase in the LIFE-5S score was associated with higher mortality risk (HR 1.36, 95% CI 1.33–1.39; p < 0.001). The model demonstrated good discrimination (AUC 0.786 in the derivation cohort and 0.785 in the validation cohort) and good calibration across score strata. To facilitate clinical application, an online calculator based on the LIFE-5S model is available (https://usuwanieelektrod.pl/life5scalculator). Conclusion The LIFE-5S score provides a simple bedside tool for long-term prognostic stratification after TLE. This model may support clinical decision-making, patient counseling, and planning of individualized follow-up strategies after TLE.

来源:Journal of Cardiovascular Electrophysiology,查看原文。版权归原作者所有。

引用

  1. Journal of Cardiovascular Electrophysiology:Development and Validation of the LIFE‐5S Score for Predicting 5‐Year Mortality After Transvenous Lead Extraction

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。